COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 680

Article download: 172

Indian Journal of Clinical and Experimental Ophthalmology


To evaluate the effect of intravitreal bevacizumab, macular grid laser and both in combination in patients of clinically significant macular edema


Full Text PDF Share on Facebook Share on Twitter


Author Details : Gunjan Prakash, Ashwini G, Himanshu Kumar Yadav, Neeraj A Awasthi

Volume : 2, Issue : 4, Year : 2016

Article Page : 387-390


Suggest article by email


Abstract

Purpose: To compare the efficacy between intravitreal bevacizumab, macular grid photocoagulation and both in combination for the treatment of clinically significant macular edema.
Methods: 21 cases of clinically significant macular edema were prospectively divided in three groups randomly. In group A, patients received bevacizumab 0.05ml intravitreally. In group B, patients received macular grid photocoagulation. In group C, patients received combination of macular grid photocoagulation and bevacizumab 0.05ml intravitreally. Central macular thickness and best corrected visual acuity were the main outcomes measured.
Results: The difference in central macular thickness and best corrected visual acuity among the groups at baseline was not statistically significant (p>0.05). There was significantly more improvement in central macular thickness and best corrected visual acuity in group C than in group A and group B at two months follow-up (p<0.05).
Conclusion: The better short term therapeutic outcomes in the group C indicates that combining intravitreal bevacizumab and macular grid photocoagulation might be more effective than intravitreal bevacizumab and macular grid photocoagulation alone for the treatment of clinically significant macular edema.

How to cite : Prakash G, Ashwini G, Yadav H K, Awasthi N A, To evaluate the effect of intravitreal bevacizumab, macular grid laser and both in combination in patients of clinically significant macular edema. Indian J Clin Exp Ophthalmol 2016;2(4):387-390

Copyright © 2016 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)